Characterization of Residual TN and HER2 Breast Carcinomas after Neoadjuvant Therapy
Por:
Fernandez, P, Rodriguez-Martinez, P, Margeli, M, Sanz, C, Munoz-Marmol, AM, Urbizu, A, Quiroga, V, Gandia, AC, Cirauqui, B, Teruel, I, Castella, E, Felip, E, Fabregat, CP, Pons, L and Leon, LH
Publicada:
1 mar 2022
Resumen:
Filiaciones:
:
Univ Autonoma Barcelona, Hosp Germans Trias & Pujol, Barcelona, Spain
Rodriguez-Martinez, P:
Hosp Badalona Germans Trias & Pujol, Badalona, Spain
:
Hosp Badalona Germans Trias & Pujol, Bardalona, Spain
:
Hosp Badalona Germans Trias & Pujol, Badalona, Spain
:
Univ Autonoma Barcelona, Hosp Germans Trias & Pujol, Barcelona, Spain
:
Hosp Badalona Germans Trias & Pujol, Badalona, Spain
:
Hosp Badalona Germans Trias & Pujol, Badalona, Spain
Gandia, AC:
Hosp Badalona Germans Trias & Pujol, Badalona, Spain
:
Catalan Inst Oncol ICO, Badalona, Spain
:
Hosp Badalona Germans Trias & Pujol, Badalona, Spain
Castella, E:
Hosp Badalona Germans Trias & Pujol, Fundacio IGTiP, Barcelona, Spain
:
Hosp Badalona Germans Trias & Pujol, Badalona, Spain
Fabregat, CP:
Hosp Badalona Germans Trias & Pujol, Badalona, Spain
Pons, L:
Inst Hlth Sci Res Germans Trias & Pujol IGTP, Badalona, Spain
Leon, LH:
Hosp Badalona Germans Trias & Pujol, Badalona, Spain
|